Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma
Clinical trial NCT01211262 · COMPLETED
Trial details
- NCT number
- NCT01211262
- Sponsor
- Immunocore Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-28
- Primary completion
- 2016-02-16
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.